Skip to content
Valuesider
Guess what? Valuesider just got better: smarter and more intuitive.
DMK Pharmaceuticals Corp

DMKPQ

DMK Pharmaceuticals Corp

DMK Pharmaceuticals Corp 13F Holders

DMKPQ Stock Ownership Activity

# of activities:
1
AVG reported price*:
$67.76
1 value investing guru has made changes to the DMK Pharmaceuticals Corp (DMKPQ) position according to the gurus' 2021 Q3 SEC quarterly report(s). The number of DMKPQ shares has been decreased by 1 super investor(s).

Which gurus or hedge funds bought DMKPQ in 2021 Q3?

According to the 2021 Q3 SEC filing(s) DMK Pharmaceuticals Corp (DMKPQ) has not been purchased by any super investor.
To see more about who is investing in DMK Pharmaceuticals Corp (DMKPQ), please go to the DMKPQ ownership page.
1 result
History Name Company % or
activity 		Shares
change 		Shares
held after* 		% change
to portfolio 		% of
portfolio 		Held since* Held for*
David Einhorn
Greenlight Capital
-70.76%
-10,109.05
4,176.66
-0.04%
0.02%
2021 Q2
≈ 0.50 years
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.